NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded $2.3 million to fund several early-career scientists who are developing novel technologies for diagnosing, preventing, and treating cancer, DRCR said yesterday.

The new Damon Runyon Rachleff Innovation Award winners each will receive $450,000 over three years to pursue projects involving a range of molecular, genomic, and other research tools for combating cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.